New pill aims to ease Lung-Heart strain in rare disease
NCT ID NCT07441278
First seen Mar 06, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study tests an oral drug called NS-863 in 177 adults with pulmonary hypertension linked to interstitial lung disease. The goal is to see if it improves blood flow in the lungs and is safe. Participants will be randomly assigned to receive the drug or a placebo for about 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE (PH-ILD) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.